These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19819428)

  • 1. Synthesis of a heparan sulfate mimetic disaccharide with a conformationally locked residue from a common intermediate.
    Fairweather JK; Karoli T; Liu L; Bytheway I; Ferro V
    Carbohydr Res; 2009 Nov; 344(17):2394-8. PubMed ID: 19819428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides.
    Liu L; Bytheway I; Karoli T; Fairweather JK; Cochran S; Li C; Ferro V
    Bioorg Med Chem Lett; 2008 Jan; 18(1):344-9. PubMed ID: 17981035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of disaccharides derived from heparin and evaluation of effects on endothelial cell growth and on binding of heparin to FGF-2.
    O'Brien A; Lynch C; O'Boyle KM; Murphy PV
    Carbohydr Res; 2004 Oct; 339(14):2343-54. PubMed ID: 15388349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
    J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of disaccharides containing 6-deoxy-α-L-talose as potential heparan sulfate mimetics.
    Fairweather JK; Liu L; Karoli T; Ferro V
    Molecules; 2012 Aug; 17(8):9790-802. PubMed ID: 22895025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template.
    Liu L; Li C; Cochran S; Jimmink S; Ferro V
    ChemMedChem; 2012 Jul; 7(7):1267-75. PubMed ID: 22615183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
    Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
    Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.
    Ornitz DM; Herr AB; Nilsson M; Westman J; Svahn CM; Waksman G
    Science; 1995 Apr; 268(5209):432-6. PubMed ID: 7536345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New set of orthogonal protecting groups for the modular synthesis of heparan sulfate fragments.
    Prabhu A; Venot A; Boons GJ
    Org Lett; 2003 Dec; 5(26):4975-8. PubMed ID: 14682743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of fibroblast growth factor 1 binding heparan sulfate domain.
    Kreuger J; Prydz K; Pettersson RF; Lindahl U; Salmivirta M
    Glycobiology; 1999 Jul; 9(7):723-9. PubMed ID: 10362842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
    Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
    Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs.
    Ye S; Luo Y; Lu W; Jones RB; Linhardt RJ; Capila I; Toida T; Kan M; Pelletier H; McKeehan WL
    Biochemistry; 2001 Dec; 40(48):14429-39. PubMed ID: 11724555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
    Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
    Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor.
    Pye DA; Kumar S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):889-95. PubMed ID: 9704022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of molecular docking calculations involving FGF-1 and FGF-2.
    Bytheway I; Cochran S
    J Med Chem; 2004 Mar; 47(7):1683-93. PubMed ID: 15027859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
    Jarvis MF; Gessner GW; Martin GE; Jaye M; Ravera MW; Dionne CA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):253-63. PubMed ID: 1383494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.